Biotech-Biotech Collaborations: Modified And Terminated Agreements, Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Sept. 17 - Nov. 17, 2004 Nov. 22, 2004
OSI, Genentech Receive FDA Approval Of Tarceva For NSCLC Nov. 22, 2004 By Aaron Lorenzo The FDA approved a new lung cancer drug, Tarceva (erlotinib), but a surprise in the agency's authorization might have driven down share values in the companies that developed it - OSI Pharmaceuticals Inc. and Genentech Inc. (BioWorld Today)Read More
RSS